Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): S$0.72 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are S$2.85 Billion. , an increase over its 2023 earnings that were of S$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year	Earnings	Change
2024	S$0.72 B	187.31%
2023	S$0.25 B	26.07%
2022	S$0.19 B	-298.51%
2021	-S$0.11 Billion	78.04%
2020	-S$56.52 Million	-55.36%
2019	-S$0.13 Billion	-33.56%
2018	-S$0.2 Billion	297.78%
2017	-S$47.91 Million	-95.68%
2016	-S$1.11 Billion	437.12%
2015	-S$0.21 Billion	23.91%
2014	-S$0.17 Billion	-29.25%
2013	-S$0.24 Billion	49.23%
2012	-S$0.16 Billion	171.11%
2011	-S$58.27 Million	103.01%
2010	-S$28.7 Million	-3903.54%
2009	S$0.75 M	-98.31%
2008	S$44.63 M	-189.7%
2007	-S$49.77 Million	51.02%
2006	-S$32.96 Million	-61.58%
2005	-S$85.76 Million	-56.59%
2004	-S$0.2 Billion	95.13%
2003	-S$0.11 Billion	12.09%
2002	-S$90.31 Million	73.19%
2001	-S$52.15 Million	18.32%
2000	-S$44.08 Million	19.65%
1999	-S$36.84 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Ultragenyx RARE	-S$0.68 Billion	-193.13%	🇺🇸 USA
Sangamo Therapeutics SGMO	-S$0.18 Billion	-124.77%	🇺🇸 USA
Esperion Therapeutics ESPR	S$10.02 M	-98.61%	🇺🇸 USA
Sanofi SNY	S$10.60 B	1,365.96%	🇫🇷 France
Amicus Therapeutics FOLD	-S$38.41 Million	-105.31%	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	S$0.28 B	-60.08%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions